Literature DB >> 10820359

The incidence of lymphoma in first-degree relatives of patients with Hodgkin disease and non-Hodgkin lymphoma: results and limitations of a registry-linked study.

O Paltiel1, T Schmit, B Adler, E A Rachmilevitz, A Polliack, A Cohen, N Haim, M B Shachar, R Epelbaum, M Barchana, R Cohen, D Ben Yehuda.   

Abstract

BACKGROUND: The precise incidence of familial Hodgkin disease (HD) and non-Hodgkin lymphoma (NHL) in first-degree relatives is unknown. Through record linkage using two population-based sources, the authors estimated the risk of HD and NHL in family members of lymphoma probands.
METHODS: The authors identified 8,037 first-degree relatives of 2,606 lymphoma cases (28.5% HD, 71.5% NHL) treated between 1970 and 1993 in 3 hospitals in Israel via the family file of the Population Registry. The authors linked this file with the Israel Cancer Registry, then calculated the standardized incidence ratio (SIR) by dividing the observed number of cases with the expected, adjusting for age, gender, calendar year, and continent of origin.
RESULTS: The family file yielded incomplete ascertainment of relatives (for 771 probands, no relatives were identified). Twenty cases of lymphoma--6 HD and 14 NHL--were identified among relatives of lymphoma patients. The SIR for HD was 1.15 (95% confidence interval [CI]: 0.42-2.51) and for NHL 1.71 (95% CI: 0.93-2.87), considering the entire population of first-degree relatives. SIRs among siblings of lymphoma probands were 3.12 (95% CI: 1.01-7.29) for HD, 2.16 (95% CI: 0.45-6.31) for NHL, and 2.68 (95% CI: 1.15-5.27) for all lymphomas. There were 4 HD/HD, 1 NHL/NHL, and 3 NHL/HD sibling pairs. For HD/HD and NHL/NHL sibling pairs, the interval between lymphoma occurrence in proband and sibling was 1-4 years, whereas for HD/NHL pairs this ranged from 16 to 21 years.
CONCLUSIONS: The risk of lymphoma among siblings of lymphoma probands was over 2.5-fold that of the general population and lower among other family members. The temporal proximity of HD/HD and NHL/NHL sibling pairs argues for environmental as well as genetic etiology. This method was hampered by incomplete data.

Entities:  

Mesh:

Year:  2000        PMID: 10820359

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  12 in total

1.  Running in the family: MALT lymphoma and autoimmune disease in mother and daughter.

Authors:  Barbara Kiesewetter; Marlene Troch; Leonhard Müllauer; Markus Raderer
Journal:  World J Gastrointest Oncol       Date:  2012-02-15

Review 2.  Familial predisposition and genetic risk factors for lymphoma.

Authors:  James R Cerhan; Susan L Slager
Journal:  Blood       Date:  2015-09-24       Impact factor: 22.113

3.  Survival patterns in patients with Hodgkin's lymphoma with a pre-existing hospital discharge diagnosis of autoimmune disease.

Authors:  Ola Landgren; Ruth M Pfeiffer; Sigurdur Y Kristinsson; Magnus Björkholm
Journal:  J Clin Oncol       Date:  2010-10-12       Impact factor: 44.544

4.  Whole exome sequencing in families at high risk for Hodgkin lymphoma: identification of a predisposing mutation in the KDR gene.

Authors:  Melissa Rotunno; Mary L McMaster; Joseph Boland; Sara Bass; Xijun Zhang; Laurie Burdett; Belynda Hicks; Sarangan Ravichandran; Brian T Luke; Meredith Yeager; Laura Fontaine; Paula L Hyland; Alisa M Goldstein; Stephen J Chanock; Neil E Caporaso; Margaret A Tucker; Lynn R Goldin
Journal:  Haematologica       Date:  2016-06-13       Impact factor: 9.941

5.  Survival patterns among lymphoma patients with a family history of lymphoma.

Authors:  Lesley A Anderson; Ruth M Pfeiffer; Joshua S Rapkin; Gloria Gridley; Lene Mellemkjaer; Kari Hemminki; Magnus Björkholm; Neil E Caporaso; Ola Landgren
Journal:  J Clin Oncol       Date:  2008-07-07       Impact factor: 44.544

6.  Population-based proband-oriented pedigree information system: application to hypertension with population-based screening data (KCIS No. 25).

Authors:  Sherry Yueh-Hsia Chiu; Li-Sheng Chen; Amy Ming-Fang Yen; Hsiu-Hsi Chen
Journal:  J Am Med Inform Assoc       Date:  2011-07-04       Impact factor: 4.497

Review 7.  Gastric MALT lymphoma: old and new insights.

Authors:  Angelo Zullo; Cesare Hassan; Lorenzo Ridola; Alessandro Repici; Raffaele Manta; Alessandro Andriani
Journal:  Ann Gastroenterol       Date:  2014

8.  Familial Aggregation of Non-Hodgkin's Lymphoma (NHL). A Case Report.

Authors:  Sandra Scm Loves; Lieuwe de Haan; Simon Mgj Daenen
Journal:  Hered Cancer Clin Pract       Date:  2006-08-15       Impact factor: 2.857

9.  Ethnic variation in medical and lifestyle risk factors for B cell non-Hodgkin lymphoma: A case-control study among Israelis and Palestinians.

Authors:  Geffen Kleinstern; Rania Abu Seir; Riki Perlman; Areej Khatib; Ziad Abdeen; Husein Elyan; Ronit Nirel; Gail Amir; Asad Ramlawi; Fouad Sabatin; Paolo Boffetta; Eldad J Dann; Meirav Kedmi; Martin Ellis; Arnon Nagler; Dina Ben Yehuda; Ora Paltiel
Journal:  PLoS One       Date:  2017-02-14       Impact factor: 3.240

10.  Combined linkage and association analysis of classical Hodgkin lymphoma.

Authors:  Alastair Lawrie; Shuo Han; Amit Sud; Fay Hosking; Timothee Cezard; David Turner; Caroline Clark; Graeme I Murray; Dominic J Culligan; Richard S Houlston; Mark A Vickers
Journal:  Oncotarget       Date:  2018-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.